1)Collaborative overview of randomised trials of antiplatelet therapy--I:Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. BMJ 308:81-107, 1994
2)Sorensen HT, et al:Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin. Am J Gastroenterol 95:2218-2224, 2000
3)Yamamoto T, et al:Gastroduodenal mucosal injury in patients on antiplatelet therapy. Thromb Res 120:465-467, 2007
4)Ng FH, et al:High incidence of clopidogrel-associated gastrointestinal bleeding in patients with previous peptic ulcer disease. Aliment Pharmacol Ther 18:443-449, 2003
5)King SB 3rd, et al:2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention;A report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. J Am Coll Cardiol 51:172-209, 2008
and non-steroidal anti-inflammatory drugs in peptic ulcer disease;A meta-analysis. Lancet 359:14-22, 2002
2)Wolfe MM, Lichtenstein DR, Singh G:Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. N Engl J Med 340:1888-1899, 1999
3)胃潰瘍ガイドラインの適用と評価に関する研究班(編):NSAID潰瘍,EBMに基づく胃潰瘍診療ガイドライン 第2版,pp101-106,じほう,2007
4)Chan FK, et al:Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 344:967-973, 2001